TCI Wealth Advisors, Inc. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 231 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$9,090
-15.1%
8640.0%0.00%0.0%
Q4 2022$10,705864
+10700.0%
0.00%
Q3 2022$0
-100.0%
8
-98.9%
0.00%
-100.0%
Q2 2022$9,0000.0%7400.0%0.00%0.0%
Q1 2022$9,000
+50.0%
740
+63.7%
0.00%0.0%
Q3 2021$6,000
+100.0%
452
+107.3%
0.00%0.0%
Q2 2021$3,000
+50.0%
218
+21.1%
0.00%0.0%
Q1 2021$2,0001800.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$188,977,00019.02%
13D Management LLC 600,431$6,923,0003.06%
BRIDGER MANAGEMENT, LLC 956,014$11,023,0002.48%
Brown Capital Management 11,641,935$134,232,0001.80%
Price Jennifer C. 520,000$5,996,0001.02%
Monarch Partners Asset Management LLC 272,425$3,141,0000.88%
ALPHASIMPLEX GROUP, LLC 10,510$121,0000.86%
Intrinsic Value Partners, LLC 54,105$624,0000.80%
CLARK ESTATES INC/NY 355,000$4,093,0000.71%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 692$60,000,0000.63%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders